Viridian Therapeutics Ors Inc (VRDN)
Deferred Revenue
$181.00K
Quarterly · Period ending: · USD
VRDN Deferred Revenue
Latest reported$181.00Kperiod ending
Latest reported$181.00Kperiod ending
VRDN Quarterly Deferred Revenue ($76.41K → $181.00K)
Quarterly deferred revenue
High-resolution chart · PNG
VRDN deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 181,000 | |
| 274,000 | |
| 367,000 | |
| 372,000 | |
| 288,000 | |
| 288,000 | |
| 288,000 | |
| 288,000 | |
| 288,000 | |
| 288,000 | |
| 288,000 | |
| 288,000 | |
| 288,000 | |
| 288,000 | |
| 288,000 | |
| 288,000 | |
| 288,000 | |
| 288,000 | |
| 289,000 | |
| 288,000 | |
| 288,000 | |
| 288,000 | |
| 301,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 4,775,000 | |
| 3,864,000 | |
| 2,962,000 | |
| 3,786,000 | |
| 4,254,000 | |
| 3,452,000 | |
| 0 | |
| 0 | |
| 4,060,000 | |
| 3,937,000 | |
| 4,098,000 | |
| 3,377,000 | |
| 1,649,000 | |
| 1,331,000 | |
| 1,149,000 | |
| 1,018,000 | |
| 713,000 | |
| 540,000 | |
| 959,000 | |
| 0 | |
| 0 | |
| 16,748 | |
| 17,976 | |
| 76,409 |